FDA Clears First Bangladesh Rx Supplies From Beximco Site
This article was originally published in Scrip
Executive Summary
Beximco Pharmaceuticals Ltd. has received US FDA approval to manufacture the antihypertensive, carvedilol, at its Tongi site in Bangladesh – the first prescription drug to be made in that country for export to the US.